139 related articles for article (PubMed ID: 234854)
41. [Effect of sodium salicylate on the collagen metabolism in adjuvant arthritis of rats].
Trnavská Z; Grimová J; Trnavský K
Fysiatr Revmatol Vestn; 1974 Dec; 52(6):340-4. PubMed ID: 4476692
[No Abstract] [Full Text] [Related]
42. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
[TBL] [Abstract][Full Text] [Related]
43. Studies on the effect of live bacillus Calmette Guerin (BCG) inoculation on some immunological and pathological aspects of chronic murine schistosomiasis mansoni.
El-Hawey AM; Abdel-Wahab KS; Abdine F; Nawara M; Henning J; Youssef G
J Egypt Med Assoc; 1978; 61(5-6):433-48. PubMed ID: 556100
[No Abstract] [Full Text] [Related]
44. Immunologic models used for the study of rheumatoid arthritis.
Jasin HE; Cooke TD; Hurd ER; Smiley JD; Ziff M
Fed Proc; 1973 Feb; 32(2):147-52. PubMed ID: 4688655
[No Abstract] [Full Text] [Related]
45. Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum.
Currey HL; Ziff M
Lancet; 1966 Oct; 2(7469):889-91. PubMed ID: 4162441
[No Abstract] [Full Text] [Related]
46. Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.
Kelley DR; Ratliff TL; Catalona WJ; Shapiro A; Lage JM; Bauer WC; Haaff EO; Dresner SM
J Urol; 1985 Jul; 134(1):48-53. PubMed ID: 3892051
[TBL] [Abstract][Full Text] [Related]
47. [Model of destructive tuberculosis in guinea pigs].
Khomenko AG; Golyshevskaia VI
Biull Eksp Biol Med; 1981 Nov; 92(11):627-9. PubMed ID: 7317648
[TBL] [Abstract][Full Text] [Related]
48. Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma.
Pinsky CM; Hirshaut Y; Wanebo HJ; Fortner JG; Miké V; Schottenfeld D; Oettgen HF
Ann N Y Acad Sci; 1976; 277(00):187-94. PubMed ID: 1069548
[No Abstract] [Full Text] [Related]
49. Efficacy and tolerance of one-third full dose bacillus Calmette-Guérin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
Pfister C; Kerkeni W; Rigaud J; Le Gal S; Saint F; Colombel M; Guy L; Wallerand H; Irani J; Soulie M;
Int J Urol; 2015 Jan; 22(1):53-60. PubMed ID: 25256813
[TBL] [Abstract][Full Text] [Related]
50. [Course of immunologic polyarthritis in rats; recurrences and evolution to chronicity].
Lacapère J; Goullet P; Daguet GL
Rev Rhum Mal Osteoartic; 1965 Oct; 32(10):574-5. PubMed ID: 5855734
[No Abstract] [Full Text] [Related]
51. On the development of adjuvant arthritis in the joint intra-articularly irradiated by radioactive yttrium 90Y resin.
Kalliomäki JL; Jalava S; Möttönen M
Scand J Rheumatol; 1974; 3(1):25-31. PubMed ID: 4420741
[No Abstract] [Full Text] [Related]
52. Suitability of experimental antigen-induced arthritis in rabbits as a model of rheumatoid arthritis.
Püschel W; Stiehl P; Rosenkranz M; Geiler G; Wiesenhaken U; Richter RF
Agents Actions Suppl; 1982; 10():243-53. PubMed ID: 6956221
[No Abstract] [Full Text] [Related]
53. Long term protection in bladder cancer following intralesional immunotherapy.
Reichert DF; Lamm DL
J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762
[TBL] [Abstract][Full Text] [Related]
54. [Diphenylamine reaction as an activity parameter in the course of adjuvant arthritis of rat].
Metzke H; Oppermann J
Z Rheumatol; 1974; 33(7-8):279-83. PubMed ID: 4428906
[No Abstract] [Full Text] [Related]
55. Changes in the resorptive power of rabbit knee joint membranes during the development of adjuvant-induced polyarthritis.
Grigor'eva VD
Bull Exp Biol Med; 1974 Oct; 77(4):388-90. PubMed ID: 4425739
[No Abstract] [Full Text] [Related]
56. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH
Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311
[TBL] [Abstract][Full Text] [Related]
57. Modulation of immunity by bacillus Calmette-Guérin (BCG).
Mitchell MS; Murahata RI
Pharmacol Ther; 1979; 4(2):329-53. PubMed ID: 386385
[No Abstract] [Full Text] [Related]
58. [Immune response in rats and mice with adjuvant disease].
Davydova TV; Evseev VA
Biull Eksp Biol Med; 1978 Oct; 86(10):462-5. PubMed ID: 568498
[TBL] [Abstract][Full Text] [Related]
59. New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Guérin (BCG) immunotherapy.
Dudelzak J; Curtis AR; Sheehan DJ; Lesher JL
J Drugs Dermatol; 2008 Jul; 7(7):684. PubMed ID: 18664162
[No Abstract] [Full Text] [Related]
60. The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin.
Bretton PR; Herr HW; Kimmel M; Whitmore WF; Laudone V; Oettgen HF; Fair WR
J Urol; 1990 Apr; 143(4):710-2; discussion 712-3. PubMed ID: 2313796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
